Lateral flow devices, or lateral flow tests, have played a significant role in helping to identify infectious individuals during the coronavirus disease 2019 (COVID-19) pandemic. They have been key ...

Following the beginning of the COVID-19 outbreak, lateral flow assays (LFAs)—the category of test strips in which the ...

Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...

Cambridge-based startup PocDoc has secured a CE mark for its artificial intelligence (AI) driven digital reader of lateral flow tests. The cloud-based system allows any smartphone or tablet to become ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

In today’s evolving diagnostic landscape, limitations in assay sensitivity and stability can quickly become barriers to reliable at-home testing. Developers and manufacturers must balance performance, ...